Marktwachstum, Größe, Anteil, Trends, Analyse der wichtigsten Akteure und Prognose für Rinderperikardklappen bis 2031

Historische Daten : 2021-2022    |    Basisjahr : 2022    |    Prognosezeitraum : 2023-2031

Marktgröße und Prognose für Rinderperikardklappen (2021 – 2031), Bericht über globale und regionale Anteile, Trends und Wachstumschancenanalyse: Nach Klappentyp (Aortenklappe, Mitralklappe, andere); Legierung (Kobalt-Chrom, Titan, Nickel-Molybdän, andere); Endbenutzer (Krankenhäuser, Herzzentren, ambulante chirurgische Zentren) und Geografie

  • Berichtsdatum : May 2024
  • Berichtscode : TIPRE00008677
  • Kategorie : Biowissenschaften
  • Status : Pending
  • Verfügbare Berichtsformate : pdf-format excel-format
  • Anzahl der Seiten : 150
Seite aktualisiert : Feb 2025

The bovine pericardial valve market size is projected to reach US$ 6.08 billion by 2031 from US$ 2.60 billion in 2022. The market is expected to register a CAGR of 9.9% in 2023–2031. Growing Reimbursement for cardiac valve surgeries is likely to remain a key Bovine Pericardial Valve market trend.

 

Bovine Pericardial Valve Market Analysis

Bovine pericardial valves are widely used in various medical applications, such as bio-prosthetic heart valves, dural closure, bone and dental membranes, and surgical buttressing. The growing number of heart valve interventions is expected to favor the development of new treatments to improve speech.  

 

Bovine Pericardial Valve Market Overview

The demand for bovine pericardial valves in cardiovascular surgeries such as aortic valve replacement and procedures for congenital heart diseases is rising due to their advantages over mechanical valves. The tissue valves, including bovine pericardium, can be used in minimally invasive surgery and in open-heart surgeries. The major advantage of these valves over mechanical valves is the avoidance of lifelong warfarin therapy to prevent the development of blood clots. Thus, the risk of stroke or embolism is low among patients preferring tissue valves to mechanical heart valves. Moreover, the bioprosthetic valves are an ideal choice for geriatric heart patients as they are more vulnerable to the bleeding side effects of warfarin during valve replacement surgery. Thus, the advantages offered by bovine pericardial bioprosthetic heart valves over mechanical valves are expected to foster the bovine pericardial valves market growth during the forecast period.

 

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Bovine Pericardial Valve Market:

Passen Sie diesen Bericht Ihren Anforderungen an

Sie erhalten kostenlos Anpassungen an jedem Bericht, einschließlich Teilen dieses Berichts oder einer Analyse auf Länderebene, eines Excel-Datenpakets sowie tolle Angebote und Rabatte für Start-ups und Universitäten.

Markt für Rinderperikardklappen: Strategische Einblicke

bovine-pericardial-valve-market
  • Holen Sie sich die wichtigsten Markttrends aus diesem Bericht.
    Dieses KOSTENLOSE Beispiel umfasst Datenanalysen, die von Markttrends bis hin zu Schätzungen und Prognosen reichen.

Bovine Pericardial Valve Market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

 

Bovine Pericardial Valve Market Drivers and Opportunities

 

Mounting Prevalence of Heart Valve Diseases to Favor Market

The rising number of aortic replacement valve surgeries globally boosts the demand for bovine pericardial valves. According to an article published by the Interdisciplinary CardioVascular and Thoracic Surgery in January 2024, a clinical trial including 148 patients who underwent surgical aortic valve replacement with Cingular bovine pericardial bioprosthesis was analyzed. The 5-year follow-up study concluded that this novel bovine pericardial aortic valve exhibited good safety and hemodynamic outcomes.

 

Expanding Applications – An Opportunity in Paediatric and Congenital Heart Diseases

Bovine pericardial valves are used in pediatric heart valve replacements and congenital heart defect repairs

.

According to an article published in Springer Link in April 2023, bovine pericardium is a common alternative to autologous pericardium. Bovine pericardium materials, including pericardial patches, exhibit varying durability depending on the implantation site and surgical technique. The positive outcomes of replacement surgeries utilizing bovine pericardial valves are anticipated for the development of specialized valve designs and sizes for children; this is likely to bring future opportunities for the bovine pericardial valve market.

 

 

Bovine Pericardial Valve Market Report Segmentation Analysis

Key segments that contributed to deriving the Bovine Pericardial Valve Market analysis are valve type, alloy, and end user.

  • Based on valve type, the bovine pericardial valve market is divided into aortic, mitral, and others. The aortic segment held a larger market share in 2023.
  • By alloy, the market is segmented into cobalt-chrome, titanium, nickel molybdenum, and others. The cobalt-chrome segment held the largest share of the market in 2023.
  • In terms of end-user, the market is segmented into hospitals, cardiac centers, and ambulatory surgical centers. The hospitals segment dominated the market in 2023.

 

Bovine Pericardial Valve Market Share Analysis by Geography

The geographic scope of the bovine pericardial valve Market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.

North America has dominated the Bovine Pericardial Valve Market. Factors such as the increasing prevalence of cardiovascular disorders, congenital heart defects, and the presence of leading market players in the region propel regional growth. Furthermore, the growing adoption of bioprostheses, such as bovine pericardial valves as an alternative to mechanical valves for heart valve interventions in the region, will further accelerate the North America bovine pericardial valve market growth. The market will likely experience growth opportunities in Canada and Mexico due to growing medical tourism and an increasing number of hospitals. Asia Pacific is likely to register the highest CAGR in the coming years.  

 

 

Bovine Pericardial Valve Market Regional Insights

The regional trends and factors influencing the Bovine Pericardial Valve Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Bovine Pericardial Valve Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Bovine Pericardial Valve Market
  • Get the Regional Specific Data for Bovine Pericardial Valve Market

Bovine Pericardial Valve

Berichtsattribut Einzelheiten
Marktgröße in 2022 US$ 2.60 Billion
Marktgröße nach 2023-2031 2023-2031
Globale CAGR (2023 - 2031) 9.9%
Historische Daten 2021-2022
Prognosezeitraum 2023-2031
Abgedeckte Segmente By Klappentyp
  • Aorta
  • Mitralklappe
By Legierung
  • Kobalt-Chrom
  • Titan
  • Nickel-Molybdän
By Endbenutzer
  • Krankenhäuser
  • Herzzentren
  • ambulante chirurgische Zentren
Abgedeckte Regionen und Länder Nordamerika
  • USA
  • Kanada
  • Mexiko
Europa
  • Großbritannien
  • Deutschland
  • Frankreich
  • Russland
  • Italien
  • Restliches Europa
Asien-Pazifik
  • China
  • Indien
  • Japan
  • Australien
  • Restlicher Asien-Pazifik
Süd- und Mittelamerika
  • Brasilien
  • Argentinien
  • Restliches Süd- und Mittelamerika
Naher Osten und Afrika
  • Südafrika
  • Saudi-Arabien
  • Vereinigte Arabische Emirate
  • Restlicher Naher Osten und Afrika
Marktführer und wichtige Unternehmensprofile
  • Edwards Lifesciences
  • Medtronic
  • Boston Scientific
  • Labor Laboratories
  • Meril Life Sciences
  • Abbott
  • Colibri Heart Valve
  • LivaNova PLC
  • Braile Biomedica
  • Affluent Medical SA
Report AttributeDetails
Market size in 2022US$ 2.60 Billion
Market Size by 2031US$ 6.08 Billion
Global CAGR (2023 - 2031)9.9%
Historical Data2021-2022
Forecast period2023-2031
Segments CoveredBy Valve Type
  • Aortic
  • Mitral
By Alloy
  • Cobalt-chrome
  • Titanium
  • Nickel Molybdenum
By End User
  • Hospitals
  • Cardiac Centers
  • Ambulatory Surgical Centers
Regions and Countries CoveredNorth America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Edwards Lifesciences
  • Medtronic
  • Boston Scientific
  • Labor Laboratories
  • Meril Life Sciences
  • Abbott
  • Colibri Heart Valve
  • LivaNova PLC
  • Braile Biomedica
  • Affluent Medical SA

 

Bovine Pericardial Valve Market Players Density: Understanding Its Impact on Business Dynamics

The Bovine Pericardial Valve Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

Major Companies operating in the Bovine Pericardial Valve Market are:

  1. Edwards Lifesciences
  2. Medtronic
  3. Boston Scientific
  4. Labor Laboratories
  5. Meril Life Sciences
  6. Abbott

Disclaimer: The companies listed above are not ranked in any particular order.


bovine-pericardial-valve-market-cagr

 

  • Get the Bovine Pericardial Valve Market top key players overview

 

Bovine Pericardial Valve Market News and Recent Developments

The Bovine Pericardial Valve Market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for bovine pericardial valves:

  • Medtronic launched the Avalus Ultra valve, designed to facilitate ease of use at implant and lifetime patient management. The product is a next-generation surgical aortic tissue valve that features a polyetheretherketone (PEEK) base frame for consistent circularity, an industry-leading Effective Orifice Area (EOA) that allows for greater blood flow and a radiopaque coil for clear visibility for future valve-in-valve procedures (Source: Medtronic, Press Release, 2024)
  • Edwards Lifesciences Corporation launched the SAPIEN 3 Ultra RESILIA valve, which incorporates the company's RESILIA tissue technology with the SAPIEN 3 Ultra transcatheter aortic heart valve. RESILIA tissue is a bovine pericardial tissue treated with advanced anti-calcification technology. It serves as the platform for new valves, including the next-generation SAPIEN X4 valve undergoing clinical trials. (Source: Edwards Lifesciences, Company Website, 2022)

 

Bovine Pericardial Valve Market Report Coverage and Deliverables

The “Bovine Pericardial Valve Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Market dynamics such as drivers, restraints, and key opportunities
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
  • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
  • Detailed company profiles
Mrinal Kelhalkar
Manager,
Forschung und Beratung

Mrinal ist eine erfahrene Research-Analystin mit über 8 Jahren Erfahrung in der Marktanalyse und Beratung im Bereich Life Sciences. Mit ihrer strategischen Denkweise und ihrem unerschütterlichen Streben nach Exzellenz hat sie sich umfassende Expertise in den Bereichen Pharmaprognosen, Marktchancenbewertung und Entwicklung von Branchen-Benchmarks angeeignet. Ihre Arbeit konzentriert sich darauf, umsetzbare Erkenntnisse zu liefern, die Kunden fundierte strategische Entscheidungen ermöglichen. Mrinals Kernkompetenz liegt in der Übersetzung komplexer quantitativer Datensätze in aussagekräftige Geschäftsinformationen. Ihr analytischer Scharfsinn ist entscheidend für die Entwicklung von Go-to-Market-Strategien (GTM) und die Erschließung von Wachstumschancen in der Pharma- und Medizinproduktebranche. Als vertrauenswürdige Beraterin konzentriert sie sich konsequent auf die Optimierung von Arbeitsabläufen und die Etablierung von Best Practices, um so Innovation und Betriebseffizienz für ihre Kunden zu fördern.

  • Historische Analyse (2 Jahre), Basisjahr, Prognose (7 Jahre) mit CAGR
  • PEST- und SWOT-Analyse
  • Marktgröße Wert/Volumen – Global, Regional, Land
  • Branchen- und Wettbewerbslandschaft
  • Excel-Datensatz

Erfahrungsberichte

Grund zum Kauf

  • Fundierte Entscheidungsfindung
  • Marktdynamik verstehen
  • Wettbewerbsanalyse
  • Kundeneinblicke
  • Marktprognosen
  • Risikominimierung
  • Strategische Planung
  • Investitionsbegründung
  • Identifizierung neuer Märkte
  • Verbesserung von Marketingstrategien
  • Steigerung der Betriebseffizienz
  • Anpassung an regulatorische Trends
Unsere Kunden
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Verkaufsunterstützung
US: +1-646-491-9876
UK: +44-20-8125-4005
Chatten Sie mit uns
DUNS Logo
87-673-9708
ISO Certified Logo
ISO 9001:2015